Shanghai First Maternity and Infant Hospital
76
14
15
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.3%
1 terminated/withdrawn out of 76 trials
88.9%
+2.4% vs industry average
11%
8 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (76)
Feasibility Effects of a Low-GI, High-fibre Diet in PCOS: a Prospective Cohort Study in Remote Yunnan
Role: lead
Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance
Role: collaborator
A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01)
Role: collaborator
Shanghai Clinical Cohort of Hyperglycemia in Pregnancy
Role: collaborator
INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma
Role: collaborator
PROfiling Based Endometrial Cancer Adjuvant Therapy
Role: collaborator
Effect of Hysteroscopic Metroplasty on Reproductive Outcome in Patients with RIF
Role: lead
Study of Time-restricted Eating (TRE) to Clinical Pregnancy Rate in PCOS Women With Glucose Metabolism Disorder Via IVF/ICSI
Role: collaborator
Comparative Effects of A2 Platinum Stage 1 Infant Formula on Infant Digestion and Comfort
Role: collaborator
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
Role: collaborator
PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer
Role: collaborator
A Cohort of Maternal Vascular Malperfusion-related FGR (CoMVMFGR)
Role: lead
Prediction of Placental Fetal Growth Restriction in High Risk Population (PoPFGR)
Role: lead
Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China
Role: collaborator
Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol
Role: lead
Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02
Role: collaborator
PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer
Role: collaborator
Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer
Role: collaborator
Improving Outcome of Very Preterm Infants Using Collaborative Quality Improvement
Role: collaborator
Aspirin Versus Metformin in Pregnancies at High Risk of Preterm Preeclampsia: a 3-arm Randomized Controlled Trial
Role: collaborator